Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 1.231% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] Cn1cc2cc([N+](=O)[O-])ccc2n1
[b] Clc1ccc(OCCN2CCCCC2)c(Cl)c1.O=C(O)C(=O)O
[c] Cc1ccc(N(CC2CO2)S(=O)(=O)c2ccccc2[N+](=O)[O-])cc1
[d] Cc1ccc(C(=O)Nc2cc([N+](=O)[O-])ccc2C)cc1
[e] CCOC(=O)C1=C(O)/C(=C/c2ccc(CNC(=O)C(=O)Nc3ccc(C)cc3)o2)N=C1C
Answer: c. Cc1ccc(N(CC2CO2)S(=O)(=O)c2ccccc2[N+](=O)[O-])cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N(CC2CO2)S(=O)(=O)c2ccccc2[N+](=O)[O-])cc1
Cc1ccc(N(CC2CO2)S(=O)(=O)c2ccccc2[N+](=O)[O-])cc1
N-(4-methylphenyl)-2-nitro-N-(oxiran-2-ylmethyl)benzenesulfonamide